Athens Medical Csa Stock Current Valuation
IATR Stock | EUR 1.94 0.03 1.52% |
Valuation analysis of Athens Medical CSA helps investors to measure Athens Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Athens Medical's price fluctuation is unstable at this time. Calculation of the real value of Athens Medical CSA is based on 3 months time horizon. Increasing Athens Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Athens Medical's intrinsic value may or may not be the same as its current market price of 1.94, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.94 | Real 2.2 | Hype 1.94 | Naive 2.09 |
The intrinsic value of Athens Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Athens Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Athens Medical CSA helps investors to forecast how Athens stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Athens Medical more accurately as focusing exclusively on Athens Medical's fundamentals will not take into account other important factors: Athens Medical CSA Company Current Valuation Analysis
Athens Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Athens Medical Current Valuation | 354.02 M |
Most of Athens Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Athens Medical CSA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Athens Medical CSA has a Current Valuation of 354.02 M. This is 97.54% lower than that of the Healthcare sector and 99.41% lower than that of the Health Care Plans industry. The current valuation for all Greece stocks is 97.87% higher than that of the company.
Athens Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Athens Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Athens Medical could also be used in its relative valuation, which is a method of valuing Athens Medical by comparing valuation metrics of similar companies.Athens Medical is currently under evaluation in current valuation category among its peers.
Athens Fundamentals
Return On Equity | 0.11 | |||
Return On Asset | 0.0317 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 354.02 M | |||
Shares Outstanding | 86.74 M | |||
Shares Owned By Insiders | 80.82 % | |||
Price To Earning | 18.79 X | |||
Price To Book | 0.59 X | |||
Price To Sales | 0.54 X | |||
Revenue | 226 M | |||
Gross Profit | 57.79 M | |||
EBITDA | 34.78 M | |||
Net Income | 15.05 M | |||
Cash And Equivalents | 4.59 M | |||
Cash Per Share | 0.05 X | |||
Total Debt | 129.39 M | |||
Debt To Equity | 184.80 % | |||
Current Ratio | 0.90 X | |||
Book Value Per Share | 1.17 X | |||
Cash Flow From Operations | 15.75 M | |||
Earnings Per Share | 0.12 X | |||
Number Of Employees | 2.8 K | |||
Beta | 1.02 | |||
Market Capitalization | 145.28 M | |||
Total Asset | 422.76 M | |||
Retained Earnings | 12 M | |||
Working Capital | (147 M) | |||
Current Asset | 124 M | |||
Current Liabilities | 271 M | |||
Z Score | 0.6 | |||
Annual Yield | 0.04 % | |||
Five Year Return | 3.50 % | |||
Net Asset | 422.76 M | |||
Last Dividend Paid | 0.07 |
About Athens Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Athens Medical CSA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Athens Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Athens Medical CSA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Athens Stock Analysis
When running Athens Medical's price analysis, check to measure Athens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athens Medical is operating at the current time. Most of Athens Medical's value examination focuses on studying past and present price action to predict the probability of Athens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athens Medical's price. Additionally, you may evaluate how the addition of Athens Medical to your portfolios can decrease your overall portfolio volatility.